This is the second webinar in the Extreme Mortality Events series presented by Chair of the Life Board of the Institute and Faculty of Actuaries, Colin Dutkiewicz who will be joined by Mei Sum Chan.
Every scientific expert you ask about COVID-19 will preface their comments by the fact that SARS-CoV-2, the virus that leads to COVID-19, is a novel virus and we just don’t know. But this doesn’t stop us grabbing onto pieces of information and building our understanding around these ‘assumed facts’. What if people aren’t asymptomatically infectious? What if herd immunity is in fact strong? What if children can get sick from the virus? This presentations aims to discuss many of these ‘assumed truths’ and challenge them as a way of helping us think more broadly about the pandemic and its impact on society and the narrower topic of insurance company experience.
A recording of the first webinar in this series, Extreme Mortality Events – How Bad is Coronavirus?, is available for members and non-members to purchase.
Colin Dutkiewicz leads Aon’s global life reinsurance team from London. He has 30 years’ experience through the full life insurance value chain. He has been a personal financial advisor, consulted on distribution management, worked in direct office product development and pricing, managed reinsurance underwriting, pricing, client management functions and held a role as a global corporate actuary for a major reinsurer.
This experience allows him to have significant insight into the issues of insurers and reinsurers alike. Most relevantly, he has conducted reviews for multinational companies across the globe, including a portfolio of over $1.5bn of pandemic insurance.
Colin is a Fellow of the Institute of Actuaries and is the Chair of the Life Board of the Institute and Faculty of Actuaries. He is also co-chairing the IFoA’s C19 Action Group. He has an MBA from the University of Cape Town.
Mei Sum Chan
Mei is a researcher in the Nuffield Department of Population Health and Big Data Institute at the University of Oxford. She is finishing her PhD on biological ageing based on clinical biomarkers and her research is mainly in the areas of ageing epidemiology, biostatistics and evidence synthesis.
Before moving to Oxford, she was a medical statistician within an interdisciplinary University College London-Legal & General collaboration investigating socioeconomic inequalities in life expectancy with multimorbidity, and she worked in various actuarial roles in life insurance at Legal & General.
Mei is a Fellow of the IFoA and a member of the IFoA COVID-19 Action Taskforce and Royal Statistical Society Oxford Local Group.
Matthew Edwards is an actuary working at Willis Towers Watson, where he leads the life practice’s demographic risk work, focusing on mortality, longevity and associated analytics. He is Chair of the CMI, Editor of the IFoA’s Longevity Bulletin and chaired the profession’s Antibiotic Resistance Working Party.
This webinar will take place from 17.00-18.00 with time at the end for Q&A.